Innovation Quotes for Environmental, Health and Safety Professionals

Sparking Innovation and Creativity

innovation quotesHere at Affygility Solutions, we often attend conferences and events that are entirely outside of the environmental, health and safety field. The purpose of attending these events is to spark innovation and creativity, so that we may drive improvements to our products and services, which will ultimately improve the value of these products and services to our customers. With that said, here our my top ten innovation quotes:

Innovation Quotes – My Top Ten

  1. “The innovations that will greatly improve environmental, health and safety performance won’t come from EH&S professionals. Rather, these innovations will come from outside the field and will be adopted to fit EH&S” – D. Calhoun, CIH.
  2. “Successful innovators ask users to embrace–or at least tolerate–new values, new skills, new behaviors, new vocabularies, new ideas, new expectations, and new aspirations. They transform their customers. Successful innovators reinvent their customers as well as their businesses. Their innovations make customers better and make better customers.” – M. Schrage, Fast Company
  3. “If you try to make an improvement, you are almost by definition in a smartness contest with all of your peers and everyone that has come before you. You probably are not going to win. But, if you try to do things ten times better, you have no hope of getting that done using traditional methods. You have to rely on bravery, creativity and perspective shifting.” A. Teller, Google
  4. “The innovators who create products at “hackathons” aren’t even trying to disrupt your business. You’re just the collateral damage.” – L. Downes and P.F. Nunes.
  5. “During the past two centuries, innovation has more than doubled our life span and given us cheap energy and more food. If we project what the world will be like 10 years from now without continuing innovation in health, energy or food, the picture is dark.” – B. Gates
  6. “Innovation is something that average people do every day to live extraordinary lives.” – C. Gallo
  7. “Innovation cannot occur in the absence of passion; without it, you have little hope of creating breakthrough ideas.” – C. Gallo
  8. “Simply innovating doesn’t guarantee success, but you’ll learn far more from the risks you take than by maintaining the status quo.” – L. Howes
  9. “Innovation almost always is not successful the first time out. You try something and it doesn’t work and it takes confidence to say we haven’t failed yet. … Ultimately you become commercially successful.” C. Christensen
  10. “Where do you put the fear when you choose to innovate? The fear is there, but you have to find a place to put it. – S. Godin.

Through attendance at these events Affygility Solutions has created such innovative services like OEL Fastrac. A service where life science companies can get immediate access to occupational exposure limit monographs for active pharmaceutical ingredients.

I hope you enjoy the above innovation quotes, and I leave you with the following questions. “Where do you get your inspiration for innovation?” “What are your favorite innovation quotes?”

 

Share and Enjoy:
  • Print
  • email
  • PDF
  • Twitter
  • LinkedIn
  • Google Buzz
  • del.icio.us
  • Digg
  • Posterous
  • Reddit
  • StumbleUpon
  • Propeller
  • Technorati
Posted in innovation | Leave a comment

Featured OEL Fastrac Monograph: Hydroxyzine

Hydroxyzine Occupational Exposure Limit (OEL) Now Immediately Available

Affygility Solutions is pleased to announce the immediate availability of the OEL Fastrac monograph for hydroxyzine. Hydroxyzine, a piperazine derivative, is a sedating antihistamine with antimuscarinic and significant sedative properties; it is also an antiemetic. Hydroxyzine is mainly used in the treatment of anxiety prior to medical procedures, and for rash with itching. The most common adverse effects reported with taking hydroxyzine compounds include drowsiness, dizziness, rapid heartbeat, dilated pupils and urinary retention. Over-exposure to hydroxyzine in an occupational setting is expected to mimic those adverse effects observed in a clinical setting.

hydroxyzine-oel-occupational-exposure-limitOEL Fastrac monographs are an affordable way to obtain high-quality, credible occupational exposure limit monographs. OEL Fastrac monographs have been used by biotechnology, pharmaceutical, and medical device companies throughout the United States, Canada, Europe, and Asia.

Click here to ORDER now.

Why OEL Fastrac Monographs?

  • Fully documented. 7-11 pages in length, with calculations and cited references.
  • Credible and reliable information. OEL Fastrac monographs are used by dozens of pharmaceutical, biotechnology and medical device companies throughout the world.
  • Expert preparation. Industry experts with advance degrees, professional certifications, and decades of experience.
  • High quality. Proprietary 18-point quality process.
  • Save time! Unsurpassed delivery with instant download.
  • Save money. Similar documents cost 5-12 times as much.
  • Stay current. Automatic notification of revisions.

 

Share and Enjoy:
  • Print
  • email
  • PDF
  • Twitter
  • LinkedIn
  • Google Buzz
  • del.icio.us
  • Digg
  • Posterous
  • Reddit
  • StumbleUpon
  • Propeller
  • Technorati
Posted in control banding, occupational toxicology, OEL Fastrac, potent compound safety | Leave a comment

Can Regulators Keep Up? Risk Assessments are Needed Now.

Yesterday, I was reading the NY Times opinion pages about “Where OSHA Falls Short, and Why” and the unfortunate event of the fertilizer plant explosion in West, Texas. Many of the opinions posted in the NY Times were along the lines of OSHA has few resources, regulations are out-dated, and empower the regulators to be tougher. While all of this may be true, it is a matter that regulatory agencies will never be able to keep up with industry, nor should they. It comes down to a matter that companies must put in management systems to correctly evaluate environmental, health and safety risks. Risk assessment processes need to be established and implemented. This should not be the regulators responsibility to perform the risk assessments for the companies. In addition, regulators will never be able to hire enough qualified inspectors to properly evaluate and follow-up on even a fraction of the highest risk facilities in the country.

For example, take the challenge of permissible exposure limits (PELs). Currently, about 500 PELs exist. But, there are literally tens of thousands of hazardous compounds that are in use today. OSHA would never be able to established PELs for even a fraction of these compounds. Industries need to take the lead similar to what has been done in the pharmaceutical industry. In the pharmaceutical industry there are thousands of active pharmaceutical ingredients that are potentially hazardous from an occupational exposure standpoint. Did occupational health professionals in the industry just sit back and say “Oh well, we will wait till OSHA passes some PELs.” No they didn’t. It is now common industry practice to develop and establish internal occupational exposure limits for the APIs that they may handle or process. The occupational health professionals then perform risk assessments, evaluate processes, and establish controls to reduce the risk.

The Risk Assessment Equation

In its most simple form, most risk assessments are based on the following equation:

Risk = (Hazard or Severity) X (Probability of Occurrence)

There are many risk assessment models that have been in use for years. These include HAZOP, What-If, Process Hazard Analysis, FEMA, and others.

So what needs to be done? Industries of every size need to step up and take the lead. They need to proactively establish risk assessment processes and implement controls to reduce risk. People can argue all they want about ineffective regulatory agenices, but in the end, they still wouldn’t be able to keep up.

Share and Enjoy:
  • Print
  • email
  • PDF
  • Twitter
  • LinkedIn
  • Google Buzz
  • del.icio.us
  • Digg
  • Posterous
  • Reddit
  • StumbleUpon
  • Propeller
  • Technorati
Posted in risk assessments | Leave a comment

Advanced Topics in Potent Compound Safety webinar series begins May 30th, 2013

Affygility Solutions is pleased to announce that its next Advanced Topics in Potent Compound Safety webinar series will begin on May 30th, 2013.

Potent Compound Safety Training From Your Own Office

potent-compound-safetyAvoid the hassle and expense of time-consuming travel. Attend this 5-module series from the convenience of your own office, or register your entire team and view in your own conference room (group discounts are available). Learn potent compound safety principles such as the definition of a potent compound, occupational exposure control banding, calculation of occupational exposure limits (OELs) for active pharmaceutical ingredients, engineering controls, and containment.

Each module is 2 hours long, with a 10-15 minute break at approximately the mid-point.

Register Early to Ensure a Spot

In order to ensure a high degree of interaction, Affygility Solutions limits the number of attendees for each module, so REGISTER EARLY. Register by May 1st, 2013 and receive 20% off each attendee by using the early discount code of “jh2mq7″ No other offers are discounts may be applied or combined.

Taught by Pharmaceutical Industry Experts

The Advanced Topics in Potent Compound Safety webinar series is taught by industry experts with advance degrees, professional certifications, and decades of pharmaceutical industry experience.

Share and Enjoy:
  • Print
  • email
  • PDF
  • Twitter
  • LinkedIn
  • Google Buzz
  • del.icio.us
  • Digg
  • Posterous
  • Reddit
  • StumbleUpon
  • Propeller
  • Technorati
Posted in control banding, potent compound safety, potent compound series | Comments Off